izpis_h1_title_alt

Extracellular vesicles from human cerebrospinal fluid are effectively separated by Sepharose CL-6B—comparison of four gravity-flow size exclusion chromatography methods
ID Krušić Alić, Vedrana (Author), ID Wechtersbach, Karmen (Author), ID Kojc, Nika (Author), ID Grabušić, Kristina (Author), et al.

.pdfPDF - Presentation file, Download (1,62 MB)
MD5: 181E55D03396290F1184333E8DF910BE
URLURL - Source URL, Visit https://www.mdpi.com/2227-9059/10/4/785 This link opens in a new window

Abstract
Extracellular vesicles (EVs) are a versatile group of cell-secreted membranous nanoparticles present in body fluids. They have an exceptional diagnostic potential due to their molecular content matching the originating cells and accessibility from body fluids. However, methods for EV isolation are still in development, with size exclusion chromatography (SEC) emerging as a preferred method. Here we compared four types of SEC to isolate EVs from the CSF of patients with severe traumatic brain injury. A pool of nine CSF samples was separated by SEC columns packed with Sepharose CL-6B, Sephacryl S-400 or Superose 6PG and a ready-to-use qEV10/70 nm column. A total of 46 fractions were collected and analysed by slot-blot followed by Ponceau staining. Immunodetection was performed for albumin, EV markers CD9, CD81, and lipoprotein markers ApoE and ApoAI. The size and concentration of nanoparticles in fractions were determined by tunable resistive pulse sensing and EVs were visualised by transmission electron microscopy. We show that all four SEC techniques enabled separation of CSF into nanoparticle- and free protein-enriched fractions. Sepharose CL-6B resulted in a significantly higher number of separated EVs while lipoproteins were eluted together with free proteins. Our data indicate that Sepharose CL-6B is suitable for isolation of EVs from CSF and their separation from lipoproteins.

Language:English
Keywords:extracellular vesicles, cerebrospinal fluid, traumatic brain injury, size exclusion chromatography, CD9 protein, CD81 protein, apolipoproteins
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:15 str.
Numbering:Vol. 10, iss. 4, art. 785
PID:20.500.12556/RUL-137627 This link opens in a new window
ISSN on article:2227-9059
DOI:10.3390/biomedicines10040785 This link opens in a new window
COBISS.SI-ID:119230211 This link opens in a new window
Publication date in RUL:23.06.2022
Views:465
Downloads:100
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biomedicines
Shortened title:Biomedicines
Publisher:MDPI AG
ISSN:2227-9059
COBISS.SI-ID:523006745 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:zunajcelični vezikli, cerebrospinalna tekočina, travmatska poškodba možganov, velikostno izločitvena kromatografija, protein CD9, protein CD81, apolipoproteini

Projects

Funder:HRZZ - Croatian Science Foundation
Project number:IP-2019-04-1511

Funder:Other - Other funder or multiple funders
Funding programme:University of Rijeka
Project number:uniri-biomed-18-5

Funder:Other - Other funder or multiple funders
Funding programme:University of Rijeka
Project number:uniri-biomed-18-279

Funder:ARRS - Slovenian Research Agency
Project number:P3-0054
Name:Patologija in molekularna genetika

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back